Erasca (ERAS) is down -9.9%, or -$2.13 to $19.36.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERAS:
- Erasca sinks after Revolution Medicines alleges patent infringement
- Erasca Highlights ERAS-0015 Phase 1 Data Update
- Erasca price target raised to $30 from $20 at Stifel
- Erasca Tightens Timeline for ERAS-0015 Phase 1 Data
- ERAS: Promising RAS-Mutant Oncology Pipeline and China Partnership Support Buy Rating